Harry Glorikian Overview
- Firm
- Scientia Venture...
- Primary Position
-
General Partner
- Primary Industry
-
Healthcare
- Active Board Seats
-
2
- Med. Deal Size
-
Harry Glorikian General Information
Biography
Mr. Harry Glorikian serves as General Partner at Scientia Ventures. He serves as Board Member at Drumroll Health. He co-founded and served as Advisor at Drawbridge Health. Previously, he co-founded Scientia Advisors with 20 years of experience in the healthcare and life science industries. He is known worldwide as a leader in helping companies streamline their operations and accelerate their growth. Having held senior management positions at Applied BioSystems, Signet Laboratories, in Massachusetts, and X-Cell Laboratories, Inc., in California, he has a deep commercial background in diagnostics, molecular biology, proteomics, and cellular biology, and biodefense. His unique understanding of technologies, operations, and strategy from both customer and industry player perspectives has shaped Scientia's sophisticated framework and proprietary analytic tools. Science was recently acquired by Precision for Medicine and he has joined the leadership team as Managing Director. A sought-after speaker, he has addressed the National Institutes of Health, Molecular Medicine Tri-Conference, and other audiences, worldwide. He has authored numerous articles for industry publications, appeared on CBS Evening News, and been quoted by Dow Jones, the Boston Globe, BioWorld Today, Los Angeles Times, London Independent, Medical Device Daily, Science Magazine, and many other media outlets. He serves on many advisory boards and is an avid investor who has several patents and patents pending in the US and abroad. He holds an MBA from Boston University and a BA in Biology from San Francisco State University.
Contact Information
Address
- One Liberty Plaza
- 46th Floor
- New York, NY 10006
- United States
Harry Glorikian Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Scientia Ventures | Investor | General Partner | New York, NY | Venture Capital |
Harry Glorikian Board Seats (2)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Drumroll AI | Media and Information Services (B2B) | Privately Held (backing) | Venture Capital-Backed | Cedar City, UT | |
StageZero Life Sciences | Diagnostic Equipment | Publicly Held | Corporation | Richmond Hill, Canada |
Harry Glorikian Lead Partner on Deals (1)
Harry Glorikian has been the lead partner on 1 deal. Their latest deal was with StageZero Life Sciences, a diagnostic equipment company. The deal was made for on 28-Apr-2016.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
StageZero Life Sciences | 28-Apr-2016 | Convertible Debt | Completed | Diagnostic Equipment | Richmond Hill, Canada |
Harry Glorikian Network (28)
Board Members (15)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Hamid Gari Ph.D | Drawbridge Health | Self | Menlo Park, CA | |
Richard Warburg Ph.D | Drumroll AI | Scientia Ventures | Cedar City, UT | |
StageZero Life Sciences | Self | Richmond Hill, Canada | ||
Drumroll AI | Self | Cedar City, UT | ||
Drawbridge Health | Self | Menlo Park, CA |
Portfolio Executives (8)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Choong Chin Liew Ph.D | StageZero Life Sciences | Co-Founder & Chief Scientist | 28-Apr-2016 | Richmond Hill, Canada |
James Howard-Tripp | StageZero Life Sciences | Chief Executive Officer & Chairman | 28-Apr-2016 | Richmond Hill, Canada |
StageZero Life Sciences | Head of Investor Relations | 28-Apr-2016 | Richmond Hill, Canada | |
StageZero Life Sciences | Chief Financial Officer & Board Member | 28-Apr-2016 | Richmond Hill, Canada | |
StageZero Life Sciences | Vice President | 28-Apr-2016 | Richmond Hill, Canada |
Fund Team Members (5)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Richard Warburg Ph.D | Scientia Ventures | New Ventures III | New York, NY |
Richard Warburg Ph.D | Redesign Health | New Ventures III | New York, NY |
Scientia Ventures | New York, NY | ||
Redesign Health | New York, NY | ||
Scientia Ventures | New York, NY |
Harry Glorikian Affiliated Funds (1)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
New Ventures III | Scientia Ventures | Venture Capital - Early Stage | Closed | 2023 |
Harry Glorikian FAQs
-
Who is Harry Glorikian?
Mr. Harry Glorikian serves as General Partner at Scientia Ventures.
-
How much does Harry Glorikian typically invest?
Harry Glorikian's median deal size is
. -
What is Harry Glorikian’s main position?
Harry Glorikian’s primary position is General Partner.
-
How many active board seats does Harry Glorikian hold?
Harry Glorikian holds 2 board seats including Drumroll AI and StageZero Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »